Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots
Shots: Arcellx’s Anito-cel, a BCMA CAR-T therapy recently got th...
Shots: Arcellx’s Anito-cel, a BCMA CAR-T therapy recently got th...
Shots: Recently EC granted Marketing Authorization to Astellas’...
Shots: Recently, the CHMP of the EMA adopted a positive opinion for As...
Shots: Our recent Spotlight interview with David Espo...
Shots: In an extended cut to our Spotlight Interview, PharmaShots pres...
Shots: Exemplifying awareness campaign at its best with a hint of cont...
Incisive News in 3 Shots.
Modal body text goes here.